We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 10,000 results
  1. A computational approach to design a multiepitope vaccine against H5N1 virus

    Since 1997, highly pathogenic avian influenza viruses, such as H5N1, have been recognized as a possible pandemic hazard to men and the...

    Fatemeh Dashti, Arash Raisi, ... Hamed Mirzaei in Virology Journal
    Article Open access 20 March 2024
  2. Q fever immunology: the quest for a safe and effective vaccine

    Q fever is an infectious zoonotic disease, caused by the Gram-negative bacterium Coxiella burnetii . Transmission occurs from livestock to humans...

    Gayathri Sam, John Stenos, ... Bernd H. A. Rehm in npj Vaccines
    Article Open access 07 September 2023
  3. In silico analysis of virulence factors of Streptococcus uberis for a chimeric vaccine design

    Streptococcus uberis is one of the causative agents of bovine mastitis, which has detrimental effects on animal health and the dairy industry....

    Çiğdem Yılmaz Çolak in In Silico Pharmacology
    Article Open access 06 January 2024
  4. Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges

    The rapid development and deployment of vaccines following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been...

    Bryce M. Warner, Jacob G. E. Yates, ... Darwyn Kobasa in npj Vaccines
    Article Open access 23 May 2024
  5. Pan-genome and reverse vaccinology approaches to design multi-epitope vaccine against Epstein-Barr virus associated with colorectal cancer

    Abstract

    Epstein-Barr virus (EBV) is a global lymphotropic virus and has been associated with various malignancies, among which colorectal cancer...

    P. Priyamvada, Sudha Ramaiah in Immunologic Research
    Article 10 July 2023
  6. A dual-antigen malaria vaccine targeting Pb22 and Pbg37 was able to induce robust transmission-blocking activity

    Background

    Despite years of effort to develop an effective vaccine against malaria infection, a vaccine that provides individuals with sufficient...

    Wenyan Gao, Yue Qiu, ... Yaming Cao in Parasites & Vectors
    Article Open access 14 December 2023
  7. Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus

    Group A Streptococcus (Strep A) is a life-threatening human pathogen with no licensed vaccine. Here, we used a biopolymer particle (BP) approach to...

    Shuxiong Chen, Victoria Ozberk, ... Bernd H. A. Rehm in npj Vaccines
    Article Open access 14 July 2023
  8. Strategies to reduce the risks of mRNA drug and vaccine toxicity

    mRNA formulated with lipid nanoparticles is a transformative technology that has enabled the rapid development and administration of billions of...

    Dimitrios Bitounis, Eric Jacquinet, ... Mansoor M. Amiji in Nature Reviews Drug Discovery
    Article 23 January 2024
  9. Integrating core subtractive proteomics and reverse vaccinology for multi-epitope vaccine design against Rickettsia prowazekii endemic typhus

    Rickettsia prowazekii is an intracellular, obligate, gram-negative coccobacillus responsible for epidemic typhus. Usually, the infected body louse or...

    Ariba Khan, Muhammad Hassan Khanzada, ... Reaz Uddin in Immunologic Research
    Article 22 August 2023
  10. Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine

    AKS-452, a subunit vaccine comprising an Fc fusion of the ancestral wild-type (WT) SARS-CoV-2 virus spike protein receptor binding domain (SP/RBD),...

    David G. Alleva, Eline A. Feitsma, ... Todd C. Zion in npj Vaccines
    Article Open access 21 February 2024
  11. A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression

    Here we report on the development and comprehensive evaluations of an mRNA vaccine for chronic hepatitis B (CHB) treatment. In two different HBV...

    Huajun Zhao, **anyu Shao, ... Yong Yang in npj Vaccines
    Article Open access 03 February 2024
  12. OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans

    The ability of Neisseria meningitidis Outer Membrane Vesicles (OMV) to induce protective responses in humans is well established and mainly...

    Viola Viviani, Adele Fantoni, ... Erika Bartolini in npj Vaccines
    Article Open access 12 April 2023
  13. Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models

    Despite the success of the widely used attenuated yellow fever (YF) vaccine, its global supply remains a substantial barrier to implementing...

    Lex G. Medina-Magües, Janine Mühe, ... Jorge E. Osorio in npj Vaccines
    Article Open access 04 March 2023
  14. Vaccines and Immunoinformatics for Vaccine Design

    The host immune system recognizes and responds to the selective antigens or epitopes (immunome) of the intruding pathogen over an entire organism....
    Shikha Joon, Rajeev K. Singla, Bairong Shen in Translational Informatics
    Chapter 2022
  15. Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

    A nasally delivered chimpanzee adenoviral-vectored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (ChAd-SARS-CoV-2-S) is...

    Baoling Ying, Tamarand L. Darling, ... Michael S. Diamond in Nature Immunology
    Article Open access 09 February 2024
  16. A report on neurogenic bladder in COVID-19 vaccine-associated acute transverse myelitis

    Introduction

    Acute transverse myelitis (ATM) is a rare neurological complication of Coronavirus disease (COVID-19) vaccines. Various vaccines have...

    Muhamad Faizal Zainudin, Mohd Razali Hasim, ... Thanalactchumy Chandrabose in Spinal Cord Series and Cases
    Article 25 April 2024
  17. Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development

    In its myriad devastating forms, Tuberculosis (TB) has existed for centuries, and humanity is still affected by it. Mycobacterium tuberculosis ( M....

    Saurabh Chugh, Ritika Kar Bahal, ... Ramandeep Singh in npj Vaccines
    Article Open access 09 March 2024
  18. Calcifediol boosts efficacy of ChAdOx1 nCoV-19 vaccine by upregulating genes promoting memory T cell responses

    The ChAdOx1 nCoV-19 (COVISHIELD) vaccine has emerged as a pivotal tool in the global fight against the COVID-19 pandemic. In our previous study...

    Himanshu Singh Saroha, Swati Bhat, ... Raman Kumar Marwaha in npj Vaccines
    Article Open access 20 June 2024
  19. Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine

    Varicella zoster virus (VZV) is a highly contagious human herpes virus responsible for causing chickenpox (varicella) and shingles (herpes zoster)....

    Anannya Bhattacharya, Lonzaric Jan, ... Antu K. Dey in npj Vaccines
    Article Open access 04 April 2024
  20. Screening of immunogenic proteins and evaluation of vaccine candidates against Mycoplasma synoviae

    Mycoplasma synoviae ( M. synoviae ) is a serious avian pathogen that causes significant economic losses to chicken and turkey producers worldwide. The...

    Guihua Zhang, Lejiabao Han, ... Huoying Shi in npj Vaccines
    Article Open access 15 August 2023
Did you find what you were looking for? Share feedback.